- Home
- GMM vs RPTX Comparison
GMM vs RPTX Comparison
Compare GMM & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- RPTX
- Stock Information
- Founded
- GMM 2017
- RPTX 2016
- Country
- GMM China
- RPTX Canada
- Employees
- GMM N/A
- RPTX N/A
- Industry
- GMM
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- RPTX Health Care
- Exchange
- GMM Nasdaq
- RPTX Nasdaq
- Market Cap
- GMM 61.9M
- RPTX 64.8M
- IPO Year
- GMM 2023
- RPTX 2020
- Fundamental
- Price
- GMM $2.69
- RPTX $1.52
- Analyst Decision
- GMM
- RPTX Strong Buy
- Analyst Count
- GMM 0
- RPTX 3
- Target Price
- GMM N/A
- RPTX $4.50
- AVG Volume (30 Days)
- GMM 22.6K
- RPTX 703.4K
- Earning Date
- GMM 08-15-2025
- RPTX 08-12-2025
- Dividend Yield
- GMM N/A
- RPTX N/A
- EPS Growth
- GMM 62.17
- RPTX N/A
- EPS
- GMM 6.37
- RPTX N/A
- Revenue
- GMM $41,360,953.00
- RPTX $1,073,000.00
- Revenue This Year
- GMM N/A
- RPTX N/A
- Revenue Next Year
- GMM N/A
- RPTX N/A
- P/E Ratio
- GMM $0.41
- RPTX N/A
- Revenue Growth
- GMM 53.82
- RPTX N/A
- 52 Week Low
- GMM $1.69
- RPTX $0.89
- 52 Week High
- GMM $15.60
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- GMM 49.83
- RPTX 52.15
- Support Level
- GMM $2.52
- RPTX $1.51
- Resistance Level
- GMM $2.80
- RPTX $1.56
- Average True Range (ATR)
- GMM 0.23
- RPTX 0.05
- MACD
- GMM -0.01
- RPTX -0.01
- Stochastic Oscillator
- GMM 36.51
- RPTX 28.57
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.